ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
Phase of Trial: Phase II
Latest Information Update: 05 Apr 2018
At a glance
- Drugs ONC 201 (Primary)
- Indications Advanced breast cancer; Endometrial cancer
- Focus Therapeutic Use
- 05 Apr 2018 According to the Oncoceutics media release, first patient has been treated in this trial.
- 17 Jan 2018 Status changed from not yet recruiting to recruiting.
- 12 Jan 2018 Planned initiation date changed from 16 Jan 2018 to 17 Jan 2018.